Sangamo Therapeutics Inc
NASDAQ:SGMO
Sangamo Therapeutics Inc
NASDAQ:SGMO
Price:
0.2619
USD
2.83%
Market Closed
Market Cap:
$93.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Sangamo Therapeutics Inc
NASDAQ:SGMO
|
US |
|
C
|
CIE Automotive SA
F:CAD
|
ES |
|
Shaw Communications Inc
TSX:SJR.B
|
CA |
|
Arcadis NV
AEX:ARCAD
|
NL |
|
Able C&C Co Ltd
KRX:078520
|
KR |
|
T
|
Tantia Constructions Ltd
NSE:TANTIACONS
|
IN |
|
ARC Minerals Ltd
LSE:ARCM
|
VG |
|
Bastogi SpA
MIL:B
|
IT |
|
B
|
Bear Creek Mining Corp
XTSX:BCM
|
CA |
|
A
|
Aktia Bank Abp
OMXH:AKTIA
|
FI |
|
Zenith Steel Pipes & Industries Ltd
NSE:ZENITHSTL
|
IN |
|
C
|
Comstock Inc
AMEX:LODE
|
US |
|
Q
|
Q & M Dental Group (Singapore) Ltd
XBER:QMBN
|
SG |
Balance Sheet
Balance Sheet Decomposition
Sangamo Therapeutics Inc
Sangamo Therapeutics Inc
Balance Sheet Decomposition is not available for
Sangamo Therapeutics Inc
Sangamo Therapeutics Inc
Balance Sheet
Sangamo Therapeutics Inc
Sangamo Therapeutics Inc
Currency: USD
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
18
|
10
|
9
|
19
|
13
|
12
|
19
|
21
|
11
|
17
|
22
|
10
|
6
|
70
|
22
|
50
|
140
|
80
|
131
|
179
|
100
|
45
|
42
|
21
|
|
| Cash Equivalents |
18
|
10
|
9
|
19
|
13
|
12
|
19
|
21
|
11
|
17
|
22
|
10
|
6
|
70
|
22
|
50
|
140
|
80
|
131
|
179
|
100
|
45
|
42
|
21
|
|
| Short-Term Investments |
35
|
34
|
25
|
28
|
41
|
69
|
45
|
64
|
50
|
67
|
42
|
83
|
173
|
140
|
121
|
194
|
260
|
282
|
510
|
198
|
177
|
36
|
0
|
0
|
|
| Total Receivables |
2
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
4
|
4
|
11
|
3
|
5
|
4
|
5
|
38
|
6
|
6
|
5
|
1
|
5
|
11
|
|
| Accounts Receivables |
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
0
|
1
|
4
|
3
|
10
|
3
|
5
|
3
|
5
|
37
|
5
|
6
|
4
|
1
|
1
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
0
|
4
|
10
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
5
|
5
|
12
|
16
|
18
|
12
|
5
|
4
|
|
| Total Current Assets |
54
|
45
|
34
|
49
|
55
|
82
|
66
|
86
|
61
|
86
|
68
|
97
|
191
|
213
|
150
|
248
|
411
|
406
|
660
|
399
|
300
|
94
|
52
|
36
|
|
| PP&E Net |
2
|
1
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
2
|
3
|
7
|
31
|
79
|
107
|
112
|
125
|
126
|
53
|
35
|
14
|
|
| PP&E Gross |
2
|
1
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
2
|
3
|
7
|
31
|
79
|
107
|
112
|
125
|
126
|
53
|
35
|
14
|
|
| Accumulated Depreciation |
2
|
3
|
4
|
4
|
4
|
5
|
5
|
1
|
2
|
3
|
3
|
4
|
4
|
5
|
6
|
7
|
9
|
12
|
17
|
25
|
37
|
51
|
40
|
42
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
0
|
0
|
0
|
55
|
53
|
58
|
54
|
51
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
40
|
39
|
43
|
40
|
38
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
13
|
9
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
13
|
39
|
47
|
0
|
0
|
1
|
0
|
22
|
51
|
88
|
30
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
6
|
11
|
15
|
17
|
19
|
18
|
2
|
1
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
40
|
39
|
43
|
40
|
38
|
0
|
0
|
0
|
|
| Total Assets |
56
N/A
|
46
-18%
|
35
-25%
|
49
+41%
|
56
+14%
|
84
+50%
|
68
-19%
|
87
+29%
|
63
-28%
|
87
+39%
|
83
-5%
|
141
+71%
|
243
+73%
|
217
-11%
|
158
-27%
|
287
+82%
|
590
+106%
|
638
+8%
|
939
+47%
|
722
-23%
|
563
-22%
|
165
-71%
|
102
-39%
|
60
-41%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
1
|
1
|
1
|
2
|
2
|
4
|
2
|
1
|
4
|
4
|
3
|
3
|
6
|
4
|
3
|
0
|
3
|
7
|
6
|
10
|
22
|
15
|
15
|
14
|
|
| Accrued Liabilities |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
4
|
6
|
7
|
6
|
15
|
22
|
22
|
49
|
31
|
34
|
21
|
20
|
26
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
1
|
4
|
3
|
5
|
8
|
12
|
1
|
0
|
2
|
3
|
10
|
10
|
5
|
30
|
53
|
41
|
101
|
88
|
55
|
12
|
10
|
2
|
|
| Total Current Liabilities |
2
|
2
|
2
|
7
|
5
|
10
|
12
|
16
|
7
|
7
|
9
|
10
|
21
|
20
|
13
|
45
|
79
|
70
|
144
|
128
|
112
|
48
|
46
|
42
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
25
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
7
|
7
|
7
|
7
|
6
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
4
|
2
|
2
|
1
|
0
|
0
|
0
|
9
|
8
|
15
|
5
|
5
|
29
|
138
|
128
|
291
|
212
|
150
|
35
|
33
|
32
|
|
| Total Liabilities |
2
N/A
|
2
-20%
|
2
+44%
|
11
+387%
|
7
-37%
|
12
+66%
|
13
+6%
|
16
+26%
|
7
-55%
|
7
+1%
|
18
+144%
|
19
+9%
|
37
+92%
|
25
-32%
|
22
-13%
|
99
+355%
|
224
+127%
|
205
-8%
|
440
+115%
|
347
-21%
|
268
-23%
|
82
-69%
|
79
-4%
|
74
-6%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
127
|
128
|
130
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
4
|
|
| Retained Earnings |
73
|
83
|
97
|
110
|
128
|
150
|
174
|
193
|
218
|
253
|
276
|
302
|
329
|
369
|
441
|
496
|
563
|
657
|
778
|
956
|
1 149
|
1 406
|
1 504
|
1 627
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
148
|
177
|
221
|
229
|
264
|
273
|
333
|
340
|
423
|
535
|
561
|
576
|
683
|
930
|
1 091
|
1 269
|
1 334
|
1 450
|
1 492
|
1 532
|
1 611
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
5
|
4
|
8
|
5
|
8
|
1
|
|
| Total Equity |
54
N/A
|
45
-18%
|
32
-28%
|
38
+17%
|
49
+29%
|
72
+48%
|
55
-23%
|
72
+30%
|
56
-22%
|
80
+43%
|
65
-19%
|
122
+88%
|
207
+70%
|
192
-7%
|
136
-29%
|
188
+38%
|
367
+95%
|
433
+18%
|
498
+15%
|
375
-25%
|
295
-21%
|
83
-72%
|
23
-73%
|
14
N/A
|
|
| Total Liabilities & Equity |
56
N/A
|
46
-18%
|
35
-25%
|
49
+41%
|
56
+14%
|
84
+50%
|
68
-19%
|
87
+29%
|
63
-28%
|
87
+39%
|
83
-5%
|
141
+71%
|
243
+73%
|
217
-11%
|
158
-27%
|
287
+82%
|
590
+106%
|
638
+8%
|
939
+47%
|
722
-23%
|
563
-22%
|
165
-71%
|
102
-39%
|
60
-41%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
25
|
25
|
25
|
31
|
35
|
40
|
41
|
45
|
45
|
53
|
53
|
62
|
69
|
70
|
71
|
86
|
102
|
116
|
142
|
146
|
167
|
178
|
213
|
351
|
|
Switch to:
Switch to:
See Also
Discover More
